0 CHECKOUT

Summary: Airport Commission of the City and County of San Francisco, California San Francisco International Airport; Joint Criteria May 11

  • ID: 1753982
  • May 2011
  • Region: Global, California
  • Standard & Poors
1 of 3

FEATURED COMPANIES

  • San Francisco Intl Arpt
  • MORE

Abstract
Standard & Poor's Ratings Services has assigned its 'AAA/A-1+' ratings to the Airport Commission of the City and County of San Francisco, Calif.'s variable-rate refunding bonds, series 36B, issued for San Francisco International Airport. We base the ratings on the application of low correlation joint-support criteria table, based on a letter of credit (LOC) from U.S. Bank N.A. (AA-/Stable/A-1+), the new LOC provider for the 36B bonds that take effect on the substitution date of May 4, 2011. The new LOC provides full principal coverage on the bonds (up to $40.6 million), and interest coverage in weekly mode at the maximum interest rate of 12%. The LOC is set to expire May 2, 2014, unless earlier terminated or delivery of...

Companies mentioned in this report are:
- San Francisco Intl Arpt
- San Francisco City & Cnty Arpt Comm

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify READ MORE >

Note: Product cover images may vary from those shown
2 of 3

- San Francisco Intl Arpt
- San Francisco City & Cnty Arpt Comm

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.